CClinicalTrials.gg
Sign In
Active, not recruitingNCT06260137Updated Feb 15, 2024

Comparison of Two Different Methods for Reducing Pain After Lung Surgery

An interventional study of Rhomboid intercostal block and Rhomboid intercostal and subserratus plane block in Postoperative Analgesia, sponsored by Uludag University. Active, not recruiting at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-15.

Sponsored by Uludag University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 3 months ago, but the record still lists the study as active, not recruiting.
  • Registered 6 months after the study started (first participant enrolled Jul 2023, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical study is to compare the effectiveness of the Rhomboid Intercostal Block and Sub-Servitus plan block and the effectiveness of the Rhomboid intercostal block in patients with video-supported thoracoscopic surgery. The main question it aims to answer is:

Which of these two blocks more effectively reduces the patients' pain?

02

Conditions studied

  • Postoperative Analgesia
03

In context

Lead sponsor

Uludag University is the lead sponsor of 141 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients in American Society of Anesthesiologists (ASA) classes I, II and III for whom VATS is planned

Exclusion criteria

Exclusion Criteria:

  • Known or suspected local anesthetic allergy
  • coagulopathy
  • injection site infection
  • history of thoracic surgery
  • serious neurological or psychiatric disorder
  • severe cardiovascular disease
  • liver failure
  • renal failure
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Rhomboid İntercostal Block (RIB)

    Procedure: Rhomboid intercostal block

  • Active comparator
    Rhomboid intercostal and subserratus plane block (RISS)

    Procedure: Rhomboid intercostal and subserratus plane block

Interventions

  • ProcedureRhomboid intercostal block

    Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle before surgery.

  • ProcedureRhomboid intercostal and subserratus plane block

    Patients will be injected with a local anesthetic drug under the rhomboid intercostal muscle and the serrates anterior muscle before surgery.

06

What researchers measure

Primary outcomes

  1. Postoperative analgesia

    Patients' VAS scores and additional analgesic needs in the first 48 hours will be evaluated. VAS (visual pain scale) corresponds to a value between 0 and 10. A value of 0 means no pain, and a value of 10 is the most severe pain.

    Time frame: first 48 hours postoperatively

07

Study locations

1 site
  • Hastane
    Bursa, 16210, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06260137
Lead sponsor
Uludag University
Responsible party
Ferhat Ustuner (Research Assistant Doctor, Uludag University) — Principal investigator
First posted
Feb 15, 2024
Start date
Jul 10, 2023
Primary completion
Jul 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Feb 15, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Uludag University

Start the discussion